BOLD vs MRVL · P/E 0.1, $24.6M cap vs P/E 100, rev $8.19B
Boundless Bio, Inc. Common Stock (BOLD) versus Marvell Technology Group Ltd (MRVL) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ.
BOLD does not have a complete income-statement cache yet.
Latest reported MRVL revenue for 2026-01-31 was $8.19B. Net income was $2.67B. Revenue was up 42.1% from 2025-02-01 to 2026-01-31. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
Not investment advice. Open the BOLD and MRVL stock pages for the full models.
Not investment advice.